Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List

Similar documents
User Guide. A. Program Summary B. Waiting List Information C. Transplant Information

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

USRDS UNITED STATES RENAL DATA SYSTEM

ESRD Dialysis Prevalence - One Year Statistics

Chapter 7: ESRD among Children, Adolescents, and Young Adults

NAPRTCS Annual Transplant Report

NAPRTCS Annual Transplant Report

Access to Heart and Lung Transplantation for Minority Populations. Cedric Sheffield, MD

Answers to Your Questions about a Change in Kidney Allocation Policy What you need to know

LUNG ALLOCATION SCORE SYSTEM UPDATE

kidney OPTN/SRTR 2012 Annual Data Report:

Access and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review

Liver and intestine transplantation: summary analysis,

Organ Procurement and Transplantation Network

Delays in Prior Living Kidney Donors Receiving Priority on the Transplant Waiting List

Kidney Transplant. Description

Organ Donation. United States and European Union Perspective

Chapter 6: Transplantation

Current status of kidney and pancreas transplantation in the United States,

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score

Kidney and Pancreas Transplantation in the United States,

Questions and Answers for Transplant Candidates about the Kidney Allocation System

Protocol. Kidney Transplant

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

OPTN/SRTR 2016 Annual Data Report: Preface

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Kidney and Pancreas Transplantation in the United States, : Access for Patients with Diabetes and End-Stage Renal Disease

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Are two better than one?

OPTN/UNOS Transplant Coordinators Committee

TA L K I N G A B O U T T R A N S P L A N TAT I O N

Appendix G Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes

NAPRTCS Annual Report

THE NORDIC LIVER TRANSPLANT REGISTRY ANNUAL REPORT Report prepared by Kristian Bjøro

NAPRTCS Annual Report

OPTN/SRTR 2014 ANNUAL DATA REPORT

Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery. Would you accept this offer?

CKD in Other Organ Transplants

The New Kidney Allocation System: What You Need to Know. Quality Insights Renal Network 3 Annual Meeting October 2, 2014

Progress in Pediatric Kidney Transplantation

Scores in kidney transplantation: How can we use them?

For more information about how to cite these materials visit

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Kidney Transplant. Policy Number: Last Review: 8/2014 Origination: 8/2001 Next Review: 8/2015

Consensus Report of the Living Donor Data Task Force, January 2009

Developing a Kidney Waiting List Calculator

Transplant Center Quality Assessment Using a Continuously Updatable, Risk-Adjusted Technique (CUSUM)

Barriers to Transplantation

Total number of live donor liver transplantation Number of patients died after transplantation Success rate of live donor liver transplantation %

Disparities in Transplantation Caution: Life is not fair.

Records. Adult Kidney Pancreas Transplant Recipient Registration Worksheet. Recipient Information. Provider Information.

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Healthcare Disparities and Need for Transplant in our Multicultural Communities

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

Commonly Asked Questions about Kidney Transplants

Kidney Transplantation

NAPRTCS Annual Report

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

U.S. changes in Kidney Allocation

Targeted Adverse Event (ADV)

Organ Transplantation Program Update

North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2005 Annual Report. Renal Transplantation. Chronic Renal Insufficiency

The New Kidney Allocation System (KAS) Frequently Asked Questions

Chapter 9. Kidney Donors. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Allocation of deceased donor kidneys. Phil Clayton NSW Renal Group 14 June 2012

Transplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

THIS chapter presents basic information about

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

living donor kidney transplantation pdf Living Kidney Donor Information » National Kidney Federation

Concepts for Kidney Allocation

Victorian Liver Transplant Unit. Annual Report Page 1

Diversity in Donation and Transplantation: Lessons from Cancer Care

A Guide to Better Living

Hepatorenal Syndrome: a Proposal for Kidney After Liver Transplantation (KALT)

Chapter IX. Pediatric End Stage Renal Disease. Incidence of Reported Pediatric ESRD

Disparities in Liver Transplant Allocation: An Update on MELD Allocation System

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

Simultaneous Pancreas Kidney Transplantation:

Chapter IV. Incidence and Causes of Treated ESRD. Methods

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Annual Statistics on Organ Replacement in Canada

Prelisting Prescription Narcotic Use: Survival Implications in Liver Transplantation

Chapter 15: Report of the Paediatric Renal Registry 1999

Case 1 AND. Treatment of HCV: Pre- vs Post- Transplant. 58 yo male, ESRD/diabetic nephropathy, HD for 3 weeks

Empowering Our Communities:

TA L K I N G A B O U T T R A N S P L A N TAT I O N UNOS. Facts and. Figures

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Lung Transplantation: Overview and the MUSC Program

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures

Update on Kidney Allocation

KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT MEDICAL (P.D.)

UCLA Kidney Exchange. An option for patients with incompatible living donors

Is a kidney transplant right for me?

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Thanks to our Speakers!

Transcription:

OPTN/UNOS Minority Affairs Committee Descriptive Data Request Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List Prepared for: Minority Affairs Committee Meeting by Teleconference Call October 20, 2006 By: Wida Cherikh, Ph.D. and Sarah Taranto Research Department United Network for Organ Sharing Table of Contents Background/Purpose... 2 Committee Request... 2 Data and Methods... 2 Results... 3

Background/Purpose Over the past years, living donation rates have substantially increased. The MAC expressed an interest in examining data that pertain to safety of living donation, particularly, with respect to individuals who have donated their organ and were subsequently placed on the waiting list due to end stage organ failure. At the May 12, 2006 meeting the Committee was presented with information on 117 prior living kidney donors and 3 prior living liver donors who were subsequently placed on the kidney and liver waiting lists. The Committee is ultimately interested in determining if the rate of being placed on the waiting list within 5-6 years is higher for previous living kidney donors who are Blacks as compared to non-blacks. It was noted that CMS data will be useful to determine whether some of the previous living donors are on maintenance dialysis without necessarily being placed on the waiting list. Note: UNOS, as the OPTN contractor, has signed a data use agreement which would allow OPTN staff to access CMS data for such purposes. The OPTN has not yet received the CMS data, but has been working through HRSA to receive it. Committee Request Contingent upon the receipt of CMS data, UNOS will link the CMS and OPTN database to determine if individuals who have donated their kidney subsequently received maintenance dialysis, and examine the limitations of the CMS data. Otherwise, provide updated data on individuals who have donated their organ and ended up on the wait list due to end stage organ failure. The data should include demographics (age, gender, ethnicity), cause of end stage organ failure, years after donation, whether they have received a transplant or not, and patient status. Data and Methods As of September 13, 2006, the OPTN has not received CMS data Therefore, the present report is still limited to individuals who have previously donated either kidney or liver and were subsequently placed on the waiting list. Starting on September 9, 1996, prior living kidney donors who were subsequently placed on the kidney waiting list may request four additional points with the appropriate documentation to the OPTN. For kidney analysis, we included candidates ever on the OPTN kidney waiting list between 1/1/1996 and 5/31/2006, and who were indicated as a previous donor, or had a prior living donation record in the OPTN living donor database as matched by SSN. For liver analysis, candidates ever on the OPTN liver waiting list between 4/1/1996 and 5/31/2006, and had a prior living donation record in the OPTN living donor database as matched by SSN were included. Note that living donor SSN was not collected prior to 4/1/1994 by the OPTN, and therefore SSN matching could not be performed for living donors recovered prior to 4/1/1994. Page 2 of 10

When available, information on age at donation and years between donation and listing is summarized. Basic waiting list demographics and waiting list outcomes of these candidates are also summarized. Relationship between the donors and the recipients, diagnosis of the recipients and diagnosis of the donors at the time of listing were ascertained on previous living donors who were found through linking the OPTN living donor and wait list databases by SSN. The Social Security Death Master File (SSDMF) is used to ascertain extra waiting list and posttransplant deaths. Information provided in this report is based the OPTN data as of August 25, 2006. Results Kidney: There were 121 previous living kidney donors who were on the kidney waiting list (WL), between 1/1/1996 and 5/31/2006. Note that since the majority of these candidates donated prior to the inception of the OPTN in 1987 or prior to 4/1/1994, their demographics and clinical characteristics at the time of donation can not be ascertained. For those cases we could not link with the OPTN data, some additional data on date of donation was obtained through phone calls to the transplant centers and from documentation provided to the OPTN in support of requests for donation points. Table 1 summarizes age at donation and years between donation and first listing. Of the 98 candidates with known age at donation, 65 (66.3%) donated their kidney between the age 18 and 34, 27 (27.6%) donated between the age of 35 and 49, and 6 (6.1%) donated between the age of 50 and 64. The median and mean age at donation was 32 and 32.1 years, respectively. Of the 98 candidates with known time of donation, 41 (41.8%) were placed on the WL between 16 and 25 years post-donation, 18 (18.4%) were placed on the WL 26 years or more postdonation, 15 (15.3%) between 11 and 15 years post-donation, 14 (14.3%) between 6 and 10 years, and 10 (10.2%) within 5 years of donation. The median and mean years from donation to listing were 18 and 17.8 years, respectively. Page 3 of 10

Table 1. Age at Donation and Years from Donation to First Listing Kidney Waiting List Candidates Indicated to be a Previous Living Kidney Donor Candidates Ever Waiting During 1/1/1996-5/31/2006 Age at Donation (Years) N % o Unknown 23 - o 18-34 65 66.3 o 35-49 27 27.6 o 50-64 6 6.1 Total 121 100.0 - Median Age at Donation 32 - Mean Age at Donation 32.1 Years from Donation to First Listing o Unknown 23 - o 0-5 10 10.2 o 6-10 14 14.3 o 11-15 15 15.3 o 16-25 41 41.8 o 26+ 18 18.4 Total 121 100.0 - Median 18 - Mean 17.8 Page 4 of 10

Table 2 summarizes basic waiting list demographics and clinical characteristics of these 121 previous living kidney donors at the time of the listing, as well as the waiting list outcome and patient status after transplant (for those who had received a transplant): Twenty one (17.4%) of these 121 previous living donors were placed on the kidney WL in 2005, 17 (14.0%) in 2002, and 11 (9.1%) in 1998, 1999 and 2003. The earliest year of listing was 1993 and the most recent was in 2006. Seventy-eight (64.5%) of these candidates were male, and 43 (35.5%) were female. Fifty-two (43.0%) of these previous donors were White, 51 (42.1%) were Black, 12 (9.9%) were Hispanic, and 2 (1.7%) each for Asian, American Indian/Alaska Natives and multiracial. Forty-nine (40.5%) of these previous donors were between 50 and 64 years old at time of listing, 48 (39.7%) were between 35 and 49 years old, and 12 (9.9%) were between 18 and 34 years and 65+. Thirty-two (26.4%) had been on the kidney WL for less than 3 months, 26 (21.5%) for >2 years, 23 (19.0%) for 1-2 years, 21 (17.4%) for 6-12 months, and 19 (15.7%) for 3-6 months. The three most common waiting list diagnoses were glomerular diseases - N=30 (24.8%), hypertensive nephrosclerosis N=23 (19.0%), and diabetes N=13 (10.7%). A total of 102 (84.2%) of these candidates have received a deceased donor kidney transplant, 5 (4.1%) received a living donor transplant, 3 (2.5%) died on the WL, 2 (1.7%) were too sick to transplant, 1 (0.8%) were removed for being too well, 1 (0.8%) transferred to another center, and 7 (5.8%) were still waiting for a transplant. Of the 107 candidates who had received a transplant, 102 (95.3%) were still alive and 5 (4.7%) died post-transplant. Page 5 of 10

Table 2. Basic WL Demographics and Clinical Characteristics Kidney WL Candidates Indicated to be a Previous Living Kidney Donor Candidates Ever Waiting During 1/1/1996-5/31/ 2006 (N=121) Year Listed N % 1993 1 0.8 1994 3 2.5 1995 3 2.5 1996 3 2.5 1997 6 5.0 1998 11 9.1 1999 11 9.1 2000 10 8.3 2001 8 6.6 2002 17 14.0 2003 11 9.1 2004 8 6.6 2005 21 17.4 2006 8 6.6 Donor Gender Female 43 35.5 Male 78 64.5 Donor Ethnicity White 52 43.0 Black 51 42.1 Hispanic 12 9.9 Asian 2 1.7 American Indian/Alaska Native 2 1.7 Multiracial 2 1.7 Age at Listing 18-34 12 9.9 35-49 48 39.7 50-64 49 40.5 65+ 12 9.9 Page 6 of 10

Waiting Time N % < 3 Months 32 26.4 3 6 Months 19 15.7 6 12 Months 21 17.4 1 2 Years 23 19.0 > 2 Years 26 21.5 Diagnosis at Listing Diabetes 13 10.7 Glomerular Diseases 30 24.8 Hypertensive Nephrosclerosis 23 19.0 Neoplasms 5 4.1 Not Reported/Unknown 1 0.8 Renovascular and Other Vascular Diseases 8 6.6 Retransplant/Graft Failure 6 5.0 Tubular and Interstitial Diseases 7 5.8 Unknown/Not Reported 22 18.2 Outcome of Registration Still Waiting 7 5.8 Deceased Donor tx, removed by tx center 95 78.5 Two Deceased Donor Transplants 4 3.3 One Deceased, One Living Donor Transplant 1 0.8 Deceased Donor Transplant, Relisted, Still Waiting 1 0.8 Too Well, Relisted, Deceased Donor Transplant 1 0.8 Refused transplant 1 0.8 Transferred to another center 1 0.8 Died 3 2.5 Candidate condition deteriorated, too sick to tx 2 1.7 Living Donor tx, removed by tx center 5 4.1 Patient Received a Transplant No 14 - Yes - Alive 102 95.3 - Died 5 4.7 TOTAL 121 100.0 Page 7 of 10

The relationship between the donors and the recipients, diagnosis of the recipients and diagnosis of the donors at the time of listing were ascertained on 29 previous living kidney donors who were found through linking the OPTN living donor and wait list databases by SSN. This information is listed in Table 3 below. Thirteen of these donors were White, 13 were Black and 3 were Hispanic Majority (22) of these donors donated to their full siblings, 5 donated to their parent, one donated to the child, and one donated to an unrelated individual Age at donation ranged from 18 to 54 years, and years from donation to listing ranged from 2 to 16 years. Diagnosis of the donors at the time of listing and diagnosis of the recipients of these donors are listed in Table 3. Table 3. Living Kidney Donors Recovered Since October 1, 1987 and on Kidney Waiting List Since 1996 Information on Living Kidney Donors and their Recipients Living Kidney Donors Recipients Ethnicity Age at Donation/ Listing Yrs from Donation to Listing Relation to Recipient Diagnosis at Listing Age at Transplant Diagnosis at Transplant Hispanic 31/43 12 Full Sibling Retransplant/Graft Failure 36 Not Reported White 46/56 9 Full Sibling Renovascular and Other Vascular Diseases 47 Prune Belly Syndrome Black 23/40 16 Child Diabetes 47 Hypertensive Nephrosclerosis Black 32/43 10 Full Sibling Other 34 Chronic Glomerulonephritis White 42/56 14 Full Sibling Unknown 47 Polycystic Kidneys Hispanic 21/34 12 Full Sibling Glomerular Disease 31 Not Reported White 33/45 11 Full Sibling Hypertensive Nephrosclerosis White 34/48 13 Full Sibling Hypertensive Nephrosclerosis 34 Chronic Glomerulonephritis 31 Hypertensive Nephrosclerosis Black 37/41 4 Full Sibling Glomerular Disease 36 Renal Cell Carcinoma Black 24/29 4 Child Unknown 39 Hypertensive Nephrosclerosis Black 34/44 10 Child Unknown 61 Diabetes-Type I Black 18/25 7 Full Sibling Renovascular and Other Vascular Disease White 29/35 6 Full Sibling Other 34 Nephritis 18 Acquired Obstructive Nephropathy Black 22/27 5 Full Sibling Glomerular Disease 28 Focal Glomerular Sclerosis White 30/43 13 Unrelated Glomerular Disease 30 Diabetes-Type I Black 26/32 5 Full Sibling Glomerular Disease 37 Hypertensive Nephrosclerosis White 54/61 6 Full Sibling Glomerular Disease 59 Focal Glomerular Sclerosis Black 37/43 5 Full Sibling Hypertensive 38 Hypertensive Nephrosclerosis Page 8 of 10

Nephrosclerosis Black 34/36 2 Child Unknown 61 Focal Glomerular Sclerosis White 25/30 4 Full Sibling Retransplant 29 Hemolytic Uremic Syndrome White 34/41 6 Child Fibromuscular Dyplasia 61 Hypertensive Nephrosclerosis Black 40/45 4 Full Sibling Chronic Pyelonephritis/ Reflux Nephropathy 43 Not Reported White 50/59 9 Full Sibling Gout 53 Membranous Glomerulonephritits Black 30/33 3 Full Sibling Parvo B19 Infection 28 Retransplant White 38/44 5 Full Sibling Malignant Hypertension 40 IGA Nephropathy Black 34/43 8 Half Sibling Diabetes Type II 50 Diabetes Type I White 34/41 6 Full Sibling Focal Glomerular Sclerosis 37 Malignant Hypertension White 51/57 6 Parent Unknown 36 Diabetes Type I Hispanic 42/52 10 Full Sibling Renal Cell Carcinoma 40 Membranous Glomerulonephritis Page 9 of 10

Liver: Between 4/1/1994 and 5/31/2006, there were 3 prior living liver donors on the liver WL: All three were White males between the age of 25 and 55 years at listing. One of the donors donated to the blood related half sibling, one to the parent, and one to the spouse. Ages of the recipients ranged from 45 to 70. Diagnoses of the recipients were cirrhosis cryptogenic (idiopathic), cirrhosis: type C, and secondary biliary cirrhosis: Caroli s disease. The three living liver donors were all put on the liver WL within 30 days of donation. Diagnoses of the previous donors at time of listing were sub-fulminant hepatic failure due to liver donation, Budd-Chiari syndrome, and other (donation related partial hepatectomy). One of the previous donors died one day after being put on the WL, another candidate received a deceased donor liver transplant within 3 days of listing, and the third candidate was removed from the WL due to condition improved. The one previous living liver donor who received a liver transplant was still alive at 4 years post-transplant. Page 10 of 10